Nuvation Bio Inc. (NUVB) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Nuvation Bio Inc. presented at the RBC Capital Markets Global Healthcare Conference 2026, highlighting its recent achievements and future goals. The company reported $18.5 million in first-quarter revenues and approximately 200 new patient starts. CEO David Hung discussed strategies for driving growth and revenue stacking moving forward.
- ▪Nuvation Bio Inc. presented at the RBC Capital Markets Global Healthcare Conference on May 20, 2026.
- ▪The company achieved $18.5 million in first-quarter revenues and around 200 new patient starts.
- ▪CEO David Hung emphasized the importance of revenue stacking as a growth strategy.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4908502-nuvation-bio-inc-nuvb-presents-at-rbc-capital-markets-global-healthcare-conference-2026"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
